Publication

Cediranib combined with carboplatin and paclitaxel in patients with metastatic or recurrent cervical cancer (CIRCCa): a randomised, double-blind, placebo-controlled phase 2 trial.

Symonds, R
; 
Gourley, C
; 
Davidson, Susan E
; 
Carty, K
; 
McCartney E
; 
Rai, D
; 
Banerjee, S
; 
Jackson, D
; 
Lord, R
; 
McCormack, M
... show 8 more
Citations
Altmetric:
Abstract
Authors
Symonds, R
Gourley, C
Davidson, Susan E
Carty, K
McCartney E
Rai, D
Banerjee, S
Jackson, D
Lord, R
McCormack, M
Hudson, E
Reed, N
Flubacher, M
Jankowska, P
Powell, M
Dive, Caroline
West, Catharine M L
Paul, J
Affiliation
Department of Cancer Studies, University of Leicester, Leicester, UK.
Description
Date
2015
Publisher
Collections
All Christie Publications
Show all metadata
Keywords
Type
Article
Citation
Cediranib combined with carboplatin and paclitaxel in patients with metastatic or recurrent cervical cancer (CIRCCa): a randomised, double-blind, placebo-controlled phase 2 trial. 2015 Lancet Oncol
Journal Title
Journal ISSN
Volume Title
URI
http://hdl.handle.net/10541/581708
Embedded videos